This Commentary addresses the FDA approval of pembrolizumab and the changes necessary in clinical practice to identify patients who would benefit from such treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067935 | PMC |
| http://dx.doi.org/10.1634/theoncologist.2017-0591 | DOI Listing |
Publication Analysis
Top Keywords
clinical practice
8
implementing keytruda/pembrolizumab
4
keytruda/pembrolizumab testing
4
testing clinical
4
practice commentary
4
commentary addresses
4
addresses fda
4
fda approval
4
approval pembrolizumab
4
pembrolizumab changes
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!